Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06055621
Title Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINE (VEN-R DASA)
Acronym VEN-R DASA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut Paoli-Calmettes
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.